VANNI, IRENE
 Distribuzione geografica
Continente #
EU - Europa 4.515
AS - Asia 694
NA - Nord America 687
Continente sconosciuto - Info sul continente non disponibili 124
SA - Sud America 61
AF - Africa 20
OC - Oceania 1
Totale 6.102
Nazione #
IT - Italia 4.410
US - Stati Uniti d'America 659
SG - Singapore 248
CN - Cina 163
VN - Vietnam 122
BD - Bangladesh 86
FR - Francia 44
BR - Brasile 43
HK - Hong Kong 27
FI - Finlandia 11
JP - Giappone 11
DE - Germania 9
GB - Regno Unito 8
AR - Argentina 7
CA - Canada 7
ID - Indonesia 7
EC - Ecuador 5
IN - India 5
JM - Giamaica 5
UZ - Uzbekistan 5
CH - Svizzera 4
IE - Irlanda 4
MA - Marocco 4
NL - Olanda 4
PH - Filippine 4
PK - Pakistan 4
PL - Polonia 4
UA - Ucraina 4
CR - Costa Rica 3
HN - Honduras 3
TN - Tunisia 3
ZA - Sudafrica 3
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
IQ - Iraq 2
KE - Kenya 2
MX - Messico 2
MY - Malesia 2
NI - Nicaragua 2
PR - Porto Rico 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BO - Bolivia 1
BS - Bahamas 1
CL - Cile 1
CO - Colombia 1
ES - Italia 1
GR - Grecia 1
GT - Guatemala 1
IL - Israele 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
MK - Macedonia 1
MU - Mauritius 1
NP - Nepal 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SC - Seychelles 1
SE - Svezia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TR - Turchia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 5.978
Città #
Genova 1.905
Genoa 1.503
Rapallo 524
Vado Ligure 380
San Jose 137
Singapore 113
Ashburn 91
Council Bluffs 39
Lauterbourg 39
Beijing 35
Ho Chi Minh City 35
Hanoi 29
Hong Kong 27
Santa Clara 20
Phoenix 16
Milan 15
Chicago 14
Buffalo 13
Helsinki 11
Los Angeles 11
New York 11
Bordighera 10
Rome 10
St Louis 10
Tokyo 9
Biên Hòa 7
Frankfurt am Main 7
Houston 7
Atlanta 5
Haiphong 5
Kingston 5
Brasília 4
Charlotte 4
Columbus 4
Dublin 4
London 4
São Paulo 4
Warsaw 4
Washington 4
Zurich 4
Buenos Aires 3
Catania 3
Da Nang 3
Dallas 3
Guangzhou 3
Hải Dương 3
Lawrenceville 3
Naples 3
Orlando 3
Philadelphia 3
Phú Thọ 3
Pittsburgh 3
Tashkent 3
Addis Ababa 2
Alexandria 2
Amsterdam 2
Ancona 2
Baghdad 2
Bari 2
Baton Rouge 2
Bellingham 2
Billings 2
Birmingham 2
Bowie 2
Bình Dương 2
Capitol Heights 2
City of London 2
Davao City 2
Dearborn 2
Denver 2
Esmeraldas 2
Fredericksburg 2
Garner 2
Gravina in Puglia 2
Greenville 2
Hoover 2
Houma 2
Jacksonville 2
Jersey City 2
Johannesburg 2
Karachi 2
Kyiv 2
Managua 2
Marietta 2
Mexico City 2
Minneapolis 2
Nairobi 2
New Delhi 2
Newark 2
Ninh Bình 2
Norwalk 2
Orangeburg 2
Orem 2
Paris 2
Petaling Jaya 2
Queens 2
Quận Bình Thạnh 2
Rabat 2
Raleigh 2
Riyadh 2
Totale 5.212
Nome #
Twenty years of molecular analyses in amyotrophic lateral sclerosis: genetic landscape of Italian patients 218
Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced non–small cell lung cancer:18F-FDG PET/CT study 207
The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients 202
Efficacy of motesanib diphosphate in non-small-cell lung cancer. 190
Belagenpumatucel-L for the treatment of non-small cell lung cancer 180
Next Generation Sequencing In Non-Small Cell Lung Cancer: New Avenues Toward The Personalized Medicine. 176
Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma 170
Current State of Target Treatment in BRAF Mutated Melanoma 165
Clinical applications of circulating tumor cells in lung cancer patients by cellsearch system 163
Insights into genetic susceptibility to melanoma by gene panel testing: Potential pathogenic variants in acd, atm, bap1, and pot1 159
Coping with formalin banning in pathology: under vacuum long-term tissue storage with no added formalin 152
Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer 152
Oral vinorelbine in the treatment of non-small-cell lung cancer. 151
Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors 147
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer 146
An improved method for HLA-B and -C supratyping 144
Next-generation sequencing workflow for NSCLC critical samples using a targeted sequencing approach by ion torrent PGM™ platform 143
Tag-based next generation sequencing: a feasible and reliable assay for EGFR T790M mutation detection in circulating tumor DNA of non small cell lung cancer patients 141
New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer 140
Afatinib for the treatment of non-small cell lung cancer 139
Molecular characterization of hospital-acquired methicillin-resistant Staphylococcus aureus strains in pediatric outbreaks using variable tandem repeat analysis with spa and ClfB typing. 137
Human leukocyte antigen-B (-Bw6/-Bw4 I 80, T 80) and human leukocyte antigen-C (-C1/-C2) subgrouping using pyrosequence analysis 135
Exosomes: a new horizon in lung cancer 132
Activating Killer Immunoglobulin Receptors and HLA-C: A successful combination providing HIV-1 control 131
Circulating cell-free DNA and circulating tumor cells as prognostic and predictive biomarkers in advanced non-small cell lung cancer patients treated with first-line chemotherapy 128
Whole-genome sequencing as standard practice for the analysis of clonality in outbreaks of meticillin-resistant Staphylococcus aureus in a paediatric setting 122
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications 120
Analysis of NADP+-dependent isocitrate dehydrogenase-1/2 gene mutations in pediatric brain tumors: Report of a secondary anaplastic astrocytoma carrying the IDH1 mutation 119
Understanding the checkpoint blockade in lung cancer immunotherapy 112
Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab 111
Development and validation of a multiplex quantitative polymerase chain reaction assay for the detection of Mollicutes impurities in human cells, cultured under good manufacturing practice conditions, and following European Pharmacopoeia requirements and the International Conference on Harmonization guidelines 108
Detection of ganciclovir resistance mutations by pyrosequencing in HCMV-infected pediatric patients 107
Vinflunine for the treatment of non-small cell lung cancer 105
A NEXT GENERATION SEQUENCING APPROACH TO GENOMIC LANDSCAPE IN MELANOMA PATIENTS: EVOLUTION OF PATIENT-SPECIFIC RESPONSE TO THERAPY 99
Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer 99
Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples 99
Relationship between the miRNA Profiles and Oncogene Mutations in Non-Smoker Lung Cancer. Relevance for Lung Cancer Personalized Screenings and Treatments 97
Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma 95
Prognostic and therapeutic implications of microRNA in malignant pleural mesothelioma 94
A sensible technique to detect mollicutes impurities in human cells cultured in GMP condition 92
The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape 84
Troubleshooting fine-tuning procedures for qPCR system design 79
Molecular Assessment in Patients with Melanoma: When and Why? 77
Germline POT1 Variants: A Critical Perspective on POT1 Tumor Predisposition Syndrome 73
Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup 73
Spontaneous control of HIV-1 viremia in a subject with protective HLA-B plus HLA-C alleles and HLA-C associated single nucleotide polymorphisms 71
Reply to the Letter to the Editor by C. Nicolazzo et al.: “Circulating cell-free DNA and circulating tumor cells as prognostic and predictive biomarkers in advanced non-small cell lung cancer patients treated with first-line chemotherapy” 65
Whole exome sequencing of independent lung adenocarcinoma, lung squamous cell carcinoma, and malignant peritoneal mesothelioma: A case report 53
Totale 6.102
Categoria #
all - tutte 25.303
article - articoli 24.589
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 354
Totale 50.246


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022445 0 0 17 39 23 33 11 133 17 66 16 90
2022/2023605 51 57 8 49 100 99 2 42 100 8 87 2
2023/2024335 8 40 14 42 22 49 11 38 18 15 8 70
2024/20251.049 25 63 34 57 142 91 142 182 61 59 96 97
2025/20261.795 257 25 110 93 245 133 255 73 170 182 143 109
2026/2027308 204 80 24 0 0 0 0 0 0 0 0 0
Totale 6.102